Ikarian Capital, LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$1,594,492
-42.1%
555,572
+1.9%
0.19%
-56.2%
Q2 2023$2,752,770
+524.2%
545,103
+242.0%
0.44%
+655.2%
Q1 2022$441,000
-44.9%
159,390
+5.9%
0.06%
-51.3%
Q4 2021$801,000
-37.0%
150,4840.0%0.12%
+32.2%
Q3 2021$1,272,000
-32.2%
150,484
-2.2%
0.09%
-40.8%
Q2 2021$1,876,000
-49.8%
153,9410.0%0.15%
+20.6%
Q1 2021$3,735,000
-60.4%
153,941
-47.6%
0.13%
-69.6%
Q4 2020$9,421,000
-13.2%
293,941
-18.1%
0.42%
-47.1%
Q3 2020$10,851,000
+45.0%
358,941
+102.2%
0.78%
+31.7%
Q2 2020$7,485,000177,5440.60%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders